Campbell Newman Asset Management Inc Halozyme Therapeutics, Inc. Transaction History
Campbell Newman Asset Management Inc
- $1.19 Billion
- Q2 2025
A detailed history of Campbell Newman Asset Management Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Campbell Newman Asset Management Inc holds 36,725 shares of HALO stock, worth $2.53 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
36,725
Previous 34,286
7.11%
Holding current value
$2.53 Million
Previous $2.19 Million
12.67%
% of portfolio
0.16%
Previous 0.2%
Shares
10 transactions
Others Institutions Holding HALO
# of Institutions
605Shares Held
127MCall Options Held
408KPut Options Held
388K-
Black Rock Inc. New York, NY17.6MShares$1.22 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$845 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$409 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$239 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$234 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.61B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...